openPR Logo
Press release

Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market to Expand at a 23.70% CAGR from 2014 to 2020

04-03-2018 03:58 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market

A new report on the global NDDS in cancer therapy market has been published by Transparency Market Research. The research, titled ‘Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,’ studies the regional markets, key growth drivers, technology segmentation, current trends, and competitive landscape. The analysts predict that the global market will progress from US$3.6 bn in 2013 to US$15.9 bn by 2020.

Novel drug delivery systems (NDDS) in cancer therapy comprises technologies such as liquid embolics, nanoparticles, and embolization devices that offer unique ways to cure cancer. In recent years, there has been increasing incidence of various types of cancer across the globe. Technological advances have led to the growth of new therapies. There have also been many developments in drug delivery systems due to the increasing government funding. All these factors have led to the growth of the global novel drug delivery systems (NDDS) in cancer therapy market.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3590

According to the publication, the global NDDS in cancer therapy market is expected to exhibit a whopping 23.70% CAGR from 2014 to 2020. However, strict government regulations and the high cost of new products can hamper the growth of the global market.

The report’s authors have segmented the global NDDS in cancer therapy market on the basis of technology and region. Based on technology, the global NDDS in cancer therapy market is classified into embolization particles, liquid embolics, and nanoparticles. In 2013, the nanoparticles drug delivery systems segment stood at US$3,307.7 mn and is projected to exhibit a 24.70% CAGR from 2014 to 2020. Nanoparticles such as Megace ES (megestrol acetate) Abraxane (paclitaxel) DepoCyt (liposomal cytarabine), DaunoXome (daunorubicin citrate), Myocet (doxorubicin), and Doxil (doxorubicin) are approved as novel drug delivery systems in cancer therapy. The liquid embolics segment is predicted to record a steady 4.90% CAGR from 2014 to 2020.

Request for TOC @ https://www.transparencymarketresearch.com/report-toc/3590

Based on region, the global NDDS in cancer therapy market is divided into Europe, Asia Pacific, North America, and Rest of the World. In 2013, North America accounted for a massive 46.6% of the global NDDS in cancer therapy market. The increasing number of cancer patients, advanced healthcare infrastructure, and favorable reimbursement policies are the factors that can be held responsible for the growth of the North America NDDS in cancer therapy market.

In 2013, Europe held a share of 29.2% in the global NDDS in cancer therapy market. Technical advancements in the development of innovative products and the increasing number of pipeline products are projected to benefit the Europe NDDS in cancer therapy market. The Asia Pacific NDDS in cancer therapy market is projected to expand at a 22.60% CAGR from 2014 to 2020, propelled by the development of economies such as India, China, Japan, and Australia.

Enquiry for discount on this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=3590

Advanced Medical Isotope Corporation, Eckert & Ziegler BEBIG, Bind Therapeutics, Polysciences, Inc., Nanobiotix, CeloNova BioSciences, Inc., Covidien, plc, EmboMedics, Inc., Cook Medical, Inc., and Mo-Sci Corporation are some of the prominent companies operating in the global NDDS in cancer therapy market.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market to Expand at a 23.70% CAGR from 2014 to 2020 here

News-ID: 1002078 • Views:

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends from
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetium‐99m
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,

All 5 Releases


More Releases for NDDS

New Drug Delivery Systems (NDDS) Market Will Exhibit an Impressive Expansion by …
The global new drug delivery systems (NDDS) market is anticipated to grow at a CAGR of 21.6% during the forecast period (2024-2031). Nanomedicine plays a significant role in various areas of healthcare, including cancer treatment, diabetes management, pain management, neurological disorders, respiratory disorders, cardiovascular diseases, and infectious diseases. It offers targeted drug delivery, reduces systemic toxicity, and enhances the effectiveness of medications through the use of different drug delivery systems such as
New Drug Delivery Systems (NDDS) Market Will Exhibit an Impressive Expansion by …
The global new drug delivery systems (NDDS) market is anticipated to grow at a CAGR of 21.6% during the forecast period (2024-2031). Nanomedicine plays a significant role in various areas of healthcare, including cancer treatment, diabetes management, pain management, neurological disorders, respiratory disorders, cardiovascular diseases, and infectious diseases. It offers targeted drug delivery, reduces systemic toxicity, and enhances the effectiveness of medications through the use of different drug delivery systems
New Drug Delivery Systems (NDDS) Market Will Exhibit an Impressive Expansion by …
The global new drug delivery systems (NDDS) market is anticipated to grow at a CAGR of 21.6% during the forecast period (2024-2031). Nanomedicine plays a significant role in various areas of healthcare, including cancer treatment, diabetes management, pain management, neurological disorders, respiratory disorders, cardiovascular diseases, and infectious diseases. It offers targeted drug delivery, reduces systemic toxicity, and enhances the effectiveness of medications through the use of different drug delivery systems
Novel Drug Delivery Systems (NDDS) Market 2021: Global Industry Analysis Report …
The Global Novel Drug Delivery Systems in cancer therapy market size was valued at USD 4.31 billion in 2016 and is projected to grow at a CAGR of 22% during the forecast period 2021-2027. The new drug delivery system (NDDS) is an approach, technology, and formulation for delivering drugs into the body. This includes targeting scientific sites inside the body. This new system helps reduce drug breakdown, increases drug availability, and
02-05-2020 | Health & Medicine
CRIFAX
Novel Drug Delivery System (Ndds) Market 2019-2028 : scope, Rising Demand, Share …
CRIFAX added a report on 'Novel Drug Delivery System (Ndds) Market Analysis Report, Global Outlook (U.S., Canada, UK, Germany, France, Italy, Spain, Netherlands, Russia, China, India, Japan, Australia, South Korea, Malaysia, Brazil, Mexico, Argentina, GCC, South Africa), Growth Potential, Competitive Market Share & Forecast, 2019 - 2028' to its database of market research collaterals consisting of overall market scenario with prevalent and future growth prospects, among other growth strategies used
Nanopartiele Drug Delivery System NDDS Global Industry Report - History, Present …
The global market size of Nanopartiele Drug Delivery System (NDDS) is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players,